Canton Strategic Holdings Inc
NASDAQ:CNTN · NASDAQ Capital Market
-$0.32 today
Vol 2.76M · Avg 0.69M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-9.0%
avg -141.5%
ROIC
-3.3%
avg -117.5%
ROA
-6.9%
avg -779.0%
Analysis
ROIC is currently the strongest return metric at -3.3% versus its period average of -117.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Mark Toomey | President | $670,414.00 | — | 55 | $0.00 | <0.01% |
Jacob Asbury | Chief Financial Officer | $388,124.00 | — | 52 | $0.00 | <0.01% |
Mark Wendland | CEO & Chairman of the Board | $358,333.00 | — | 47 | $0.00 | <0.01% |
Angela Dominy Radkowski | Chief Operating Officer | — | — | 37 | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
8
$343,882.44
Net Sentiment
$343,882.44
Net selling
Most Active
Stetz Gary S.
8 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 8 sells worth $343,882.44 over the last 12 months. That adds up to net selling of $343,882.44. Stetz Gary S. was the most active insider with 8 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A0 analysts |
| Net Income | N/A | N/A | N/A | N/A0 analysts |
| EBIT | N/A | N/A | N/A | N/A0 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Adlai Nortye Ltd.
NASDAQ:ANL
$536.37M
Apollomics, Inc.
APLM
$17.89M
Lunai Bioworks Inc.
LNAI
$17.55M
Moleculin Biotech, Inc.
MBRX
$15.37M
BioLineRx Ltd.
BLRX
$13.63M
Adaptimmune Therapeutics plc
ADAP
$12.53M
SeaStar Medical Holding Corporation
ICU
$8.71M
Ainos, Inc.
AIMD
$8.60M
GeoVax Labs, Inc.
GOVX
$1.15M
Aditxt, Inc.
ADTX
$429.00
Who manages CNTN?
Canton Strategic Holdings Inc (CNTN) lists 4 active executives. The top listed executive is Angela Dominy Radkowski, Chief Operating Officer.
Are CNTN insiders buying or selling?
Recent insider activity shows net buying of $1.85M.
Explore More
Continue the stock analysis
Jump to another research area for this company.